Ghana has rejected a proposed U.S. “America First” health aid deal, putting on hold tens of millions of dollars in new funding over concerns that the agreement would give Washington sweeping access to the country’s health data and digital infrastructure. Officials in Accra, backed by local experts and civil‑society groups, argue that health information on Ghanaian citizens should not be traded for financing, framing the decision as a test case for African data sovereignty in an era when global health money increasingly comes tied to digital‑data conditions.
The deal Ghana said no to
The proposed agreement was part of the Trump administration’s “America First Global Health Strategy”, a new package of bilateral deals that Washington has been rolling out across Africa, offering multi‑year funding in exchange for tighter disease‑surveillance targets and extensive use of U.S.–managed digital systems. Africa Confidential reports that similar memoranda with other states run for five years and can be worth hundreds of millions to over a billion dollars, tied to benchmarks such as the “7‑1‑7 Rule”, detect a threat in seven days, notify in one, respond in seven.
In Ghana’s case, sources cited by Africa Intelligence say Washington’s draft would have required the Ministry of Health to route core surveillance, laboratory, and patient‑level data through U.S.–hosted platforms and satellite‑linked systems, giving U.S. agencies long‑term access to anonymized and, in some cases, identifiable datasets. In return, Ghana would receive a package of health‑system support for areas such as pandemic preparedness, HIV, TB, and maternal health, with co‑financing obligations on Accra’s side.
While detailed figures for Ghana have not been publicly disclosed, analysts note that other “America First” deals run into hundreds of millions of dollars over five years, at a time when global health budgets are tightening and U.S. funding through older schemes like PEPFAR has plateaued or declined.
Why Accra balked: data sovereignty and past scandals
Behind the scenes, Ghana’s hesitation reflects years of domestic unease over who controls the country’s health data. A recent controversy over the Lightwave Health Information Management System (LHIMS), where a private firm’s standoff with the Ministry of Health forced some National Health Insurance Scheme facilities back to paper records, has sharpened public sensitivity to data monopolies and digital overreach.
Opinion essays and policy briefs from Ghanaian experts argue that health data is “the most personal form of information a citizen can share” and must remain under clear public custody, not outsourced, or stored in cloud systems governed by foreign law. Ghana’s Data Protection Act, 2012 (Act 843) and a growing community of digital‑rights advocates have pushed the state to treat health information as a sovereignty issue, not just a technical one.
A widely circulated analysis by public‑health strategist Kwesi Mbir argues that the U.S. strategy effectively offers “five years of declining funding in exchange for decades of data access, with no binding obligation to share the benefits of new vaccines or treatments” that might be developed using African datasets. In his view, Accra’s refusal is a calculated decision to “bet on its own taxpayers”, for example by lifting caps on a National Health Insurance levy, rather than trading away control over national health information.
A wider African backlash against Washington’s terms
Ghana is not alone. African media and policy trackers say Zimbabwe, Zambia and South Africa have also rejected, paused, or sought to renegotiate similar U.S. agreements over concerns that clauses on data access, pharmaceutical packages and even critical‑minerals concessions are too intrusive.
Africa Confidential reports that Zimbabwe’s President Emmerson Mnangagwa walked away from a planned US$367 million health‑funding deal in February after complaining that Washington wanted wide‑ranging access to Zimbabwean health data without firm guarantees that resulting medical breakthroughs would be affordable or prioritized for Zimbabweans. In Zambia, a leaked draft revealed that a US$1.012 billion package required Lusaka to hire 40,000 new health workers and commit an extra US$400 million over five years, with failure triggering U.S. termination rights, conditions activists criticized as onerous and potentially destabilizing.
At the continental level, the Africa CDC has openly warned about data‑access asymmetries, with its director saying, “We want to own our data in Africa. We want to own our future,” even as the institution pledges technical support regardless of whether states sign or reject Washington’s offers.
The cost of saying no
Rejecting a major U.S. health funding package is not a cost‑free decision. Ghana remains a lower‑middle‑income country with significant health‑system gaps, particularly in rural areas, and has long relied on U.S. assistance for HIV, malaria, immunization, and health‑systems support. A PBS report from 2025, before the latest deals were on the table, warned that sustained cuts to USAID and related programs could lead to millions of preventable deaths across multiple countries and strain Ghana’s ability to fight disease and poverty.
Policy analysts note that by turning down Washington’s new terms, Accra risks short‑term funding gaps, delayed projects and pressure on its already stretched budget, especially as it services debt and manages economic headwinds. Ghana’s government has signaled it will try to plug some of the hole through domestic revenue, multilateral lenders, and diversified partnerships, including with European states and the World Health Organization, but those avenues can be slower and more conditional than bilateral grants.
Supporters of the decision argue that accepting long‑term data concessions for short‑term financial relief would lock Ghana into an unfavorable bargain, leaving future generations with limited control over how their health information is used in AI systems, pharmaceutical trials, or commercial analytics.
Global health funding meets digital health politics
The standoff reveals how global health and digital governance have become intertwined. Commentaries in ICT and health‑policy outlets say Washington’s strategy formalizes a trend in which access to national digital‑health data is written into health‑funding contracts as a core condition, not a side issue.
Advocates of the U.S. approach insist that fast, cloud‑based systems and shared datasets are essential to detect emerging pathogens and meet benchmarks like the “7‑1‑7 Rule” for outbreak response. But critics counter that the current deals lack strong reciprocity and safeguards, offering no binding guarantees that countries contributing data will receive timely, equitable access to resulting vaccines, diagnostics, or therapeutics.
Scholars proposing an Integrated Data Sovereignty Framework (IDSF) for African healthcare say agreements should be built on three pillars: clear national ownership and custody of data, transparent rules for cross‑border sharing, and enforceable benefit‑sharing mechanisms when foreign entities profit from African datasets. Ghana’s stance, they argue, is a de facto demand for such a framework before signing away new layers of access.
What Accra wants instead
Ghanaian experts are not rejecting digital health or international cooperation outright; rather, they are calling for a “sovereignty‑first” model. That includes:
- Keeping legal custody of national health data with Ghanaian public institutions, even if technical management is outsourced.
- Ensuring that any foreign‑hosted systems are governed by contracts aligned with Ghana’s Data Protection Act and subject to local oversight and audit.
- Demanding explicit benefit‑sharing clauses in deals that use Ghanaian data for AI training, pharmaceutical R&D or commercial analytics.
At a 2025 digital‑health dialogue, Ghanaian health‑tech leaders warned that poor data systems and weak regulation could derail AI’s promise in healthcare, urging reforms so that data collected in clinics actually reaches policymakers and is translated into equitable improvements in care.
Seen in that light, the rejection of the U.S. deal is also a domestic governance move: a push to fix Ghana’s own data‑handling and regulatory weaknesses rather than embed them into long‑term external agreements.
A test case for Africa’s digital health future
For other African governments, Ghana’s decision is being watched closely as they weigh their own negotiations with Washington and other major funders. The World Health Organization, which held a high‑level summit on health sovereignty in Accra in 2025, has urged African states to build digital‑health strategies that respect national laws, human rights and data‑protection norms while still engaging in global surveillance networks.
As global health financing becomes more entangled with AI, cloud platforms and cross‑border data flows, the central question for countries like Ghana is no longer just “how much money?” but “on what terms?”
By refusing a U.S. package that it believes asks too high a price in data access, Ghana has chosen to prioritize control over its digital health‑future, a stance that may bring immediate budget pain but could influence how the next generation of global health deals are written across the continent.